BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/12/2023 8:10:41 AM | Browse: 191 | Download: 679
 |
Received |
|
2022-12-24 09:07 |
|
Peer-Review Started |
|
2022-12-24 09:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-02-10 20:22 |
|
Revised |
|
2023-02-20 07:52 |
|
Second Decision |
|
2023-03-22 03:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-03-22 18:28 |
|
Articles in Press |
|
2023-03-22 18:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-27 08:10 |
|
Publish the Manuscript Online |
|
2023-04-12 08:10 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Se Jun Park, Kabsoo Shin, In-Ho Kim, Tae Ho Hong, Younghoon Kim and Myung-ah Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Myung-ah Lee, MD, PhD, Professor, Division of Medical Oncology, Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, 222 Banpo-daero, Secho-gu, Seoul, Seoul 06591, South Korea. angelamd@catholic.ac.kr |
| Key Words |
Ampulla of Vater carcinoma; Adjuvant chemotherapy; Prognosis; Recurrence |
| Core Tip |
To date, there is no standard adjuvant treatment for patients with ampulla of Vater (AoV) carcinoma after surgical resection. In this study, we evaluated the effectiveness and safety of adjuvant fluorouracil-based chemotherapy. Of 104 patients investigated, 52 were received 5-fluorouracil-based adjuvant chemotherapy and 52 were observed without any adjuvant treatment. Adjuvant chemotherapy could improve disease-free survival in patients with AoV cancer following surgery, but overall survival was not associated with adjuvant chemotherapy. Treatment related adverse events were manageable. Further studies are warranted to identify patients with resected AoV cancer who might benefit from adjuvant chemotherapy. |
| Publish Date |
2023-04-12 08:10 |
| Citation |
Park SJ, Shin K, Kim IH, Hong TH, Kim Y, Lee MA. Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma. World J Gastrointest Oncol 2023; 15(4): 677-688 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i4/677.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i4.677 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
